Edgar Filing: ICU MEDICAL INC/DE

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

LOPEZ GEORGE A

2. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE [ICUI]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

__X__ Director	_____ 10% Owner
__X__ Officer (give title below)	__X__ Other (specify below)
Chairman / Chairman

(Last)

(First)

(Middle)

951 CALLE AMANECER

3. Date of Earliest Transaction (Month/Day/Year)
12/05/2008

(Street)

SAN CLEMENTE, CA 92673

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	12/05/2008	12/05/2008	S		544	D	$ 32.07	773,902	D
Common Stock	12/05/2008	12/05/2008	S		261	D	$ 32.08	773,641	D
Common Stock	12/05/2008	12/05/2008	S		6	D	$ 32.09	773,635	D
Common Stock	12/05/2008	12/05/2008	S		1,646	D	$ 32.1	771,989	D
Common Stock	12/05/2008	12/05/2008	S		1,400	D	$ 32.11	770,589	D
Common Stock	12/05/2008	12/05/2008	S		600	D	$ 32.12	769,989	D
Common Stock	12/05/2008	12/05/2008	S		224	D	$ 32.13	769,765	D
Common Stock	12/05/2008	12/05/2008	S		300	D	$ 32.14	769,465	D
Common Stock	12/05/2008	12/05/2008	S		700	D	$ 32.15	768,765	D
Common Stock	12/05/2008	12/05/2008	S		100	D	$ 32.16	768,665	D
Common Stock	12/05/2008	12/05/2008	S		1,120	D	$ 32.17	767,545	D
Common Stock	12/05/2008	12/05/2008	S		190	D	$ 32.18	767,355	D
Common Stock	12/05/2008	12/05/2008	S		1,532	D	$ 32.19	765,823	D
Common Stock	12/05/2008	12/05/2008	S		400	D	$ 32.2	765,423	D
Common Stock	12/05/2008	12/05/2008	S		500	D	$ 32.21	764,923	D
Common Stock	12/05/2008	12/05/2008	S		400	D	$ 32.22	764,523	D
Common Stock	12/05/2008	12/05/2008	S		100	D	$ 32.23	764,423	D
Common Stock	12/05/2008	12/05/2008	S		600	D	$ 32.24	763,823	D
Common Stock	12/05/2008	12/05/2008	S		410	D	$ 32.25	763,413	D
Common Stock	12/05/2008	12/05/2008	S		200	D	$ 32.28	763,213	D
Common Stock	12/05/2008	12/05/2008	S		100	D	$ 32.295	763,113	D
Common Stock	12/05/2008	12/05/2008	S		200	D	$ 32.315	762,913	D
Common Stock	12/05/2008	12/05/2008	S		100	D	$ 32.32	762,813	D
Common Stock	12/05/2008	12/05/2008	S		100	D	$ 32.34	762,713	D
Common Stock	12/05/2008	12/05/2008	S		300	D	$ 32.35	762,413	D
Common Stock	12/05/2008	12/05/2008	S		300	D	$ 32.36	762,113	D
Common Stock	12/05/2008	12/05/2008	S		200	D	$ 32.37	761,913	D
Common Stock	12/05/2008	12/05/2008	S		400	D	$ 32.38	761,513	D
Common Stock	12/05/2008	12/05/2008	S		200	D	$ 32.45	761,313	D
Common Stock								1,186,843	I	by Partnership ⁽¹⁾

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Non-Qualified Stock Option (right to buy)

$ 8.1667

12/05/2008

39,366

01/01/2002

01/02/2009

Common Stock

39,366

⁽²⁾

96,053

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
LOPEZ GEORGE A 951 CALLE AMANECER SAN CLEMENTE, CA 92673	X		Chairman	Chairman

Signatures

By: Lynn DeMartini For: George A. Lopez, M.D.		12/05/2008
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Common Stock owned by George A. Lopez M.D. Second Family Limited Partnership. Dr. Lopez holds a one-percent general partnership interest in the Partnership. As general partner, he has the power to vote and power to dispose of the 1,186,843 shares owned by the Partnership and may be deemed to be beneficial owner of such shares. The Partnership acquired the shares on 2/24/99 from Trusts for the benefit of the Lopez children, the Christopher George Lopez Children's Trust and the Nicholas George Lopez Children's Trust, which own a 99% limited partnership in the Partnership. Dr. Lopez is not trustee of and has no interest in the children's Trusts. Except to the extent of his undivided one percent general partnership interest in the assets of the Partnership, Dr. Lopez disclaims any beneficial ownership of the shares owned by the Partnership.
(2)	Transaction is the exercise of a derivative security; see Column 2.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.